Time-restricted eating shows potential in Huntington's and weight management studies

Recent clinical studies have explored the safety and efficacy of time-restricted eating (TRE) across different health contexts.

A 12-week pilot study conducted by Oregon Health & Science University found that time-restricted eating is safe and feasible for patients in the early stages of Huntington’s disease. The study, which involved twenty participants, focused on whether a restricted eating window could manage metabolic dysfunction without causing harmful weight loss. Researchers reported that the intervention was well-tolerated, with participants avoiding unintended weight loss and showing improvements in certain biomarkers linked to nerve cell damage.

Separately, researchers at Johns Hopkins Medicine investigated the effects of a 10-hour eating window on adults with obesity and prediabetes or type 2 diabetes. By ensuring calorie intake remained consistent between the TRE group and a control group, the study aimed to isolate the effects of meal timing. The results showed a modest median weight loss of 2.7% in the TRE group, compared to 2.5% in the control group. While the schedule led to positive changes in eating habits, researchers did not identify unique biological health benefits beyond those associated with weight loss.